RECIDA THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01
Phase 1
Terminated
- Conditions
- Safety
- Interventions
- Drug: Single intravenous doses of RC-01Drug: Multiple intravenous doses of RC-01Drug: Multiple intravenous doses of placeboDrug: Single intravenous doses of placebo
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Recida Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03832517
- Locations
- 🇺🇸
Celerion, Phoenix, Arizona, United States
News
No news found